Joseph Truluck's most recent trade in Adial Pharmaceuticals Inc was a trade of 25,000 Stock Option (Right to Buy) done . Disclosure was reported to the exchange on March 25, 2024.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Adial Pharmaceuticals Inc | Joseph Truluck | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Mar 2024 | 25,000 | 25,000 | - | - | Stock Option (Right to Buy) | |
| Adial Pharmaceuticals Inc | Joseph Truluck | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 May 2023 | 157,500 | 265,139 (2%) | 1% | 0 | Common Stock | |
| Adial Pharmaceuticals Inc | Joseph Truluck | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 May 2023 | 125,000 | 125,000 | - | - | Stock Option (Right to Buy) | |
| Adial Pharmaceuticals Inc | Joseph Truluck | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Feb 2022 | 100,000 | 100,000 | - | - | Employee Stock Option | |
| Adial Pharmaceuticals Inc | Joseph Truluck | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Feb 2021 | 125,000 | 125,000 | - | - | Employee Stock Option |